Global health vs. global wealth: Looming choice for health firms in developing countries
McLaughlin-Rotman Centre for Global Health 14 September 2010 The lure of greater profits elsewhere in the world may divert bio-pharmaceutical […]
McLaughlin-Rotman Centre for Global Health 14 September 2010 The lure of greater profits elsewhere in the world may divert bio-pharmaceutical […]
McLaughlin-Rotman Centre for Global Health 10 May 2010 ‘South-South’ biotech collaborations boost health, economies: Study The availability of more affordable
Biotalent Canada / Bioscience Education Canada Ottawa / Toronto 27-Apr-2010 Research by a 14-year-old science prodigy from Saskatoon into the
Rockefeller University New York City 28-Dec-2009 Two New York City high school students exploring their homes using the latest high-tech
16-Nov-2009 Global Alliance for Chronic Diseases Agencies managing 80 percent of global public health research funding set first priorities for
McLaughlin-Rotman Center for Global Health 3 Nov 2009 Experts propose ‘Global Health Accellerator’ to help new drugs, diagnostics, vaccines reach
DIVERSITAS, Paris 11-Oct-2009 Growing water needs, mismanagement leading to ‘catastrophic decline’ in freshwater biodiversity The world will miss its
McLaughlin-Rotman Centre for Global Health 9 Sep 2009 Lower manufacturing, clinical trial, R&D costs of developing country partners equal major
Encyclopedia of Life Smithsonian Institution, Washington DC 23-Aug-2009 Over 30,000 still images and video, as well as local information about
Global Alliance for Chronic Diseases London / Washington / Toronto 15-Jun-2009 Six of the world’s foremost health agencies, collectively managing